Literature DB >> 1657122

Identification of a new eph-related receptor tyrosine kinase gene from mouse and chicken that is developmentally regulated and encodes at least two forms of the receptor.

F G Sajjadi1, E B Pasquale, S Subramani.   

Abstract

We have identified cDNA clones that encode a new member of the Eph receptor tyrosine kinase subclass by using antibodies to phosphotyrosine to screen a chicken embryonic cDNA expression library. These cDNAs were in turn used to isolate the entire coding sequence of this receptor from both mouse and chicken (designated Mek4 and Cek4, respectively). A cDNA that encodes a putative secreted form of the murine receptor's ligand-binding domain and lacks the transmembrane and kinase domains was also isolated. Analysis of the appropriate Mek4 genomic region revealed the presence of sequences required for the production of the secreted form of the receptor. Analysis of RNAs from various tissues shows the receptor to be highly expressed in mouse and chicken embryos, with the greatest levels of expression occurring in the brain. In adult mouse, the pattern of RNA expression is altered and appears to be confined primarily to the brain. However, a shorter transcript was found to be expressed at reduced levels in the testis. This new Eph-related receptor may play an important role during development and in signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1657122

Source DB:  PubMed          Journal:  New Biol        ISSN: 1043-4674


  17 in total

1.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-01-11       Impact factor: 16.971

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

3.  Purification of a ligand for the EPH-like receptor HEK using a biosensor-based affinity detection approach.

Authors:  M Lackmann; T Bucci; R J Mann; L A Kravets; E Viney; F Smith; R L Moritz; W Carter; R J Simpson; N A Nicola; K Mackwell; E C Nice; A F Wilks; A W Boyd
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

4.  The N-terminal globular domain of Eph receptors is sufficient for ligand binding and receptor signaling.

Authors:  J P Labrador; R Brambilla; R Klein
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

5.  Crucial genes and pathways in chicken germ stem cell differentiation.

Authors:  Zhentao Zhang; Ahmed Kamel Elsayed; Qingqing Shi; Yani Zhang; Qisheng Zuo; Dong Li; Chao Lian; Beibei Tang; Tianrong Xiao; Qi Xu; Guobin Chang; Guohong Chen; Lei Zhang; Kehua Wang; Yingjie Wang; Kai Jin; Yilin Wang; Jiuzhou Song; Hengmi Cui; Bichun Li
Journal:  J Biol Chem       Date:  2015-04-06       Impact factor: 5.157

6.  EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.

Authors:  S Charmsaz; F Al-Ejeh; T M Yeadon; K J Miller; F M Smith; B W Stringer; A S Moore; F-T Lee; L T Cooper; C Stylianou; G T Yarranton; J Woronicz; A M Scott; M Lackmann; A W Boyd
Journal:  Leukemia       Date:  2016-12-06       Impact factor: 11.528

7.  Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.

Authors:  Erika M Lisabeth; Carlos Fernandez; Elena B Pasquale
Journal:  Biochemistry       Date:  2012-02-08       Impact factor: 3.162

8.  Biological and biochemical activities of a chimeric epidermal growth factor-Elk receptor tyrosine kinase.

Authors:  V Lhoták; T Pawson
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

9.  A novel tyrosine kinase-related sequence on mouse chromosome 5.

Authors:  J D Inglis; M Lee
Journal:  Mamm Genome       Date:  1993       Impact factor: 2.957

10.  EPHA7 and EPHA10 Physically Interact and Differentially Co-localize in Normal Breast and Breast Carcinoma Cell Lines, and the Co-localization Pattern Is Altered in EPHB6-expressing MDA-MB-231 Cells.

Authors:  Candace Johnson; Briana Segovia; Raj P Kandpal
Journal:  Cancer Genomics Proteomics       Date:  2016 09-10       Impact factor: 4.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.